UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - IDENIX PHARMACEUTICALS INC ownership

IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 93 filers reported holding IDENIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of IDENIX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$880,000
+201.4%
36,496
-24.7%
0.00%
Q1 2014$292,000
+0.7%
48,4960.0%0.00%
Q4 2013$290,000
+18.9%
48,496
+3.4%
0.00%
Q3 2013$244,000
+44.4%
46,8960.0%0.00%
Q2 2013$169,00046,8960.00%
Other shareholders
IDENIX PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Baupost Group 29,665,693$153,965,0004.40%
Bain Capital Public Equity Management, LLC 12,664,950$65,731,0001.65%
BRIDGER MANAGEMENT, LLC 4,360,628$22,632,0001.62%
12 West Capital Management LP 1,782,100$9,249,0001.32%
GENERAL AMERICAN INVESTORS CO INC 858,979$4,458,0000.39%
BB BIOTECH AG 1,250,000$6,488,0000.35%
Aris Wealth Services, Inc. 30,000$156,0000.28%
ARROWGRASS CAPITAL PARTNERS (US) LP 800,400$4,154,0000.16%
Visium Asset Management, LP 1,307,132$6,810,0000.15%
Old West Investment Management, LLC 59,038$306,0000.15%
View complete list of IDENIX PHARMACEUTICALS INC shareholders